Nvidia, Vertex Pharmaceuticals And More On CNBC’s ‘Final Trades’
Alibaba Group Holding Ltd. Sponsored ADR BABA | 0.00 | |
NVIDIA Corporation NVDA | 0.00 | |
Vertex Pharmaceuticals Incorporated VRTX | 0.00 | |
CRINETICS PHARMACEUTICALS, INC. CRNX | 0.00 | |
Roundhill Memory ETF DRAM | 0.00 |
On CNBC’s “Halftime Report Final Trades,” Bryn Talkington, managing partner of Requisite Capital Management, named Roundhill Memory ETF (NASDAQ:DRAM) as her final trade.
Jim Lebenthal, partner and chief market strategist at Cerity Partners, picked Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) after the company agreed to acquire Crinetics Pharmaceuticals (NASDAQ:CRNX).
On Monday, Crinetics and Vertex entered into a definitive agreement under which Vertex will acquire Crinetics for $85 per share in cash, representing a total equity value of approximately $10 billion.
Don’t forget to check out our premarket coverage here
Liz Young Thomas, SoFi’s head of investment strategy, recommended Vanguard Real Estate Index Fund ETF Shares (NYSE:VNQ).
Joseph M. Terranova, senior managing director for Virtus Investment Partners, picked NVIDIA Corporation (NASDAQ:NVDA).
Nvidia shares gained Wednesday following reports suggesting China will let the top AI firms buy a limited amount of Nvidia H200 chips.
Chinese officials recently told Alibaba Group Holding Limited (NYSE:BABA), ByteDance and DeepSeek that they may soon receive permission to purchase some Nvidia H200 chips, the Information reported on Wednesday, citing people familiar with the matter.
Price Action
- Vertex shares fell 4.6% to close at $498.43 on Wednesday.
- Roundhill Memory ETF rose 2.4% during the session.
- Nvidia shares gained 3.7% to close at $204.12 on Wednesday.
- Vanguard Real Estate Index Fund ETF Shares fell 1.6% during the session.
Photo via Shutterstock